Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

807

Participants

Timeline

Start Date

January 31, 1996

Primary Completion Date

July 31, 1997

Study Completion Date

July 31, 1999

Conditions
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational AgeInfant, PrematureBronchopulmonary DysplasiaRespiration, ArtificialRespiratory Distress Syndrome, NewbornSepsis
Interventions
DRUG

Vitamin A

5,000 IU (0.1 ml) was given on Mondays, Wednesdays, and Fridays for four weeks.

OTHER

Sham Procedure

Control infants received a sham procedure rather than placebo injections.

Trial Locations (11)

20052

George Washington University, Washington D.C.

30303

Emory University, Atlanta

33136

University of Miami, Miami

38163

University of Tennessee, Memphis

44106

Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland

45267

Cincinnati Children's Medical Center, Cincinnati

46202

Indiana University, Indianapolis

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

94304

Stanford University, Palo Alto

06504

Yale University, New Haven

02905

Brown University, Women & Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

lead

NICHD Neonatal Research Network

NETWORK

NCT01203488 - Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants | Biotech Hunter | Biotech Hunter